AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Pluri Inc.

Regulatory Filings Oct 29, 2017

6990_rns_2017-10-29_8777bb1a-db72-441d-9941-27dc2afccc32.htm

Regulatory Filings

Open in Viewer

Opens in native device viewer

_________ false

�������� ��������� ���� 2 380
PLURISTEM THERAPEUTICS INC
Corporation no: C12337-2001 8544
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 29/10/2017
www.isa.gov.il www.tase.co.il Reference: 2017-02-094462 Time of broadcast: 08:59 08:58:33

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on�������� ��������� ����. ����� ���� ��� ������

����_�����_������_������_�����_final_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 25/09/2017
Address: Matam Park 5 , Haifa 31905   ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: [email protected]   Company site: www.pluristem.com
Previous names of reporting entity:
Name of the Signatory: Aberman Zalman Position of Signatory in the reporting corporation: Chairman Of The Board & CEO Name of Employer Company:
Address: Matam Park 20 , Haifa 31905 Telephone: 074-7107171 Facsimile: 074-7107172 E-mail: [email protected] 2

Talk to a Data Expert

Have a question? We'll get back to you promptly.